Por: WPLG Local 10 Health January 21, 2023
BOSTON – A subsidiary of health care company Johnson & Johnson has agreed to pay nearly $10 million to settle allegations that it violated federal and state law by providing free products to a surgeon to induce him to use its products in procedures, prosecutors said Friday.Under the settlement with DePuy Synthes, the company acknowledges and accepts responsibility for giving the surgeon implants and instruments for spinal surgeries from 2013... + full article
Associated Press USA Health January 21, 2023
BOSTON (AP) — A subsidiary of health care company Johnson & Johnson has agreed to pay nearly $10 million to settle allegations that it violated federal and state law by providing free products to a surgeon to induce him to use its products in procedures, prosecutors said... + más
J&J subsidiary to pay $9.75M to resolve kickback allegations | WPLG Local 10
Biogen pays $900M to settle doctor kickback allegations | Orlando Sentinel
Forbes USA Business December 25, 2022
In Part II, I review the commonly used corporate techniques to shelter profits in overseas low tax havens and why an ESG investor might want to push for more transparent jurisdiction by jurisdiction data. I suggest a tentative role model of what such disclosures should look... + más
Why Investors Need Better Corporate Tax Disclosures- Part I | Forbes
Tax As A Component Of ESG | Forbes
Associated Press USA Health September 28, 2022
BOSTON (AP) — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs, federal prosecutors said.The agreement announced Monday settles a whistleblower... + más
Biogen to pay $900M to settle allegations of improper physician kickbacks | Fox Business
ABC News USA Health September 28, 2022
BOSTON -- Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs, federal prosecutors said.The agreement announced Monday settles a whistleblower lawsuit... + más
Orlando Sentinel USA Business September 27, 2022
BOSTON — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs, federal prosecutors said. The agreement announced Monday settles a whistleblower... + más
Biogen pays $900M to settle doctor kickback allegations | ABC News
ABC News USA Business September 27, 2022
Chicago Tribune USA Business September 27, 2022
About iurex | Privacy Policy | Disclaimer |